2020-10-23T12:19:28-07:00 2019-12-31 990 2019-01-01 236434390 THE WISTAR INSTITUTE OF ANATOMY & BIOLOGY WIST 2154956922 3601 Spruce Street Philadelphia PA 191044265 Joseph G Trainor Chief Financial Officer 2154956922 2020-10-23 108.2.74.20 2019 2021-01-29 14:40:06Z Joseph Trainor 3601 Spruce Street Philadelphia PA 19104 107836000 0 X www.wistar.org X 1892 PA Biomedical research with special expertise in cancer research and vaccine development (immunology). 32 32 391 55 190000 0 51780000 48234000 4020000 4197000 6882000 5837000 19163000 6191000 81845000 64459000 0 0 0 0 30493000 32156000 0 0 1239000 39027000 36546000 69520000 68702000 12325000 -4243000 303805000 320484000 71440000 70320000 232365000 250164000 The mission of the Wistar Institute is to marshal the talents of outstanding scientists through a highly enabled culture of biomedical collaboration and innovation in order to solve some of the world's most challenging and important problems in the field of cancer and immunology, and produce ground-breaking advances in world health. Consistent with a pioneering legacy of leadership in not-for-profit biomedical research and a track-record of life-saving contributions in immunology and cell biology, The Wistar Institute aims to pursue novel and courageous research paths to life science discovery, and to accelerate/potentiate the impact of those discoveries by shortening the path from bench to bedside. 0 0 53715000 4197000 Collaboration is one of The Wistar Institute's core traditional strengths. The Institute takes a team science-based approach to catalyzing new discoveries and helping translate basic scientific findings into next-generation therapeutics and diagnostics through meaningful partnerships. Researchers at Wistar operate within the frameworks of the Cancer Center and the Vaccine & Immunotherapy Center. Within the Cancer Center's program cores, researchers benefit from the technological support and instrumentation provided by Wistar's Shared Resources facilities. Wistar's expertise in cancer research, infectious diseases and vaccines, combined with the ability to work with partners to move advances from the laboratory to the clinic as quickly as possible, have led to the marketed vaccines against rubella, rabies and rotavirus. As a National Cancer Institute (NCI)-designated cancer center, Wistar's cutting edge research investigations are leading to significant insights into the underlying mechanisms of disease to create new targeted therapies and immunotherapies for cancer. Committed to improving health, eradicating disease, and expanding the boundaries of knowledge through research and training, the Institute works collaboratively with its partners to ensure the rapid advancement of biomedical research. 0 0 0 53715000 1 1 0 1 0 0 0 1 0 1 1 1 0 1 1 1 1 0 0 0 1 0 0 0 1 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 1 1 0 0 1 131 0 391 1 1 1 0 0 0 0 1 1 0 0 0 0 0 0 X 32 32 1 0 0 0 0 1 0 1 1 0 0 1 1 1 1 1 1 1 1 0 AL AR AZ CA CO CT FL GA HI IL KS KY MA MD ME MI MN MO MS NC ND NH NJ NM NY OH OK OR PA RI SC TN UT VA WA WI WV X Joseph G Trainor CFO 2154956922 3601 Spruce Street Philadelphia PA 191044265 Dario Altieri MD President & CEO, Director of Wistar Cancer Center 55.00 X 628055 0 40108 Luis Montaner Professor Vice President, Scientific Operations 55 X 447902 0 59720 David B Weiner Executive Vice President 55.00 X 396167 0 36184 Dmitry Gabrilovich Professor 55 X 342327 0 48212 Jennifer Evans Stacey Vice President, Gen Counsel, Sec & Gov Relations 55 X 331461 0 44600 Heather A Steinman VP for Business Develop & E. D. Tech 55 X 326843 0 39611 Rugang Zhang Professor 55 X 287846 0 50012 Frank Rauscher Professor 55 X 266251 0 53990 Meenhard Herlyn Professor 55 X 258203 0 54635 Joseph Trainor Chief Financial Officer 55 X 255201 0 47868 Anita Pepper Vice President, Institutional Advancement 55.00 X 229234 0 29191 JoAnn Mendel Vice President, Human Resources 55.00 X 201562 0 31245 Elizabeth McKee Anderson Trustee 1 X 0 0 0 Douglas S Briggs Trustee 1 X 0 0 0 Ira Brind Trustee 1 X 0 0 0 Ronald Caplan Trustee 2 X 0 0 0 Morton Collins PhD Trustee 1 X 0 0 0 Arthur Dantchik Trustee 1 X 0 0 0 Susan B Dillon PhD Trustee 1 X 0 0 0 Brian H Dovey Trustee 2 X 0 0 0 Daniel K Fitzpatrick Trustee 0.25 X 0 0 0 Robert Fox Trustee 2 X 0 0 0 John Fry Trustee 1 X 0 0 0 Joseph A Goldblum Trustee 2 X 0 0 0 Richard M Horowitz Trustee - Board Vice Chair 4 X X 0 0 0 Herbert Kean MD Trustee 0.25 X 0 0 0 Perry A Lerner Trustee 1 X 0 0 0 James W Lovett Trustee 1 X 0 0 0 Susan S McDonald PhD Trustee 1 X 0 0 0 Maida Milone Trustee 1 X 0 0 0 Abraham L Morris Trustee 1 X 0 0 0 Arthur M Pappas Trustee 1 X 0 0 0 Wendell Pritchett PhD Trustee 1 X 0 0 0 Helen P Pudlin Esq Trustee - Board Chair 1 X X 0 0 0 Cavan Redmond Trustee 1 X 0 0 0 Samuel V Rhoads Trustee 1 X 0 0 0 Robert H Rock Trustee 1 X 0 0 0 Gerald B Rorer Trustee 1 X 0 0 0 Adele K Schaeffer Trustee 1 X 0 0 0 Milton S Schneider Trustee 1 X 0 0 0 William A Slaughter Trustee 1 X 0 0 0 Judith E Soltz Trustee 1 X 0 0 0 Daniel H Wheeler Trustee 1 X 0 0 0 Edward Ziff PhD Trustee 1 X 0 0 0 3971052 0 535376 63 0 1 0 The Arthur Jackson Company 7025 West Chester Pike Upper Darby PA 19082 Janitorial services 745000 W H Myers Construction Co 5219 N Lawrence Street Philadelphia PA 19120 Construction 571000 Mara Restoration Inc 150 Roesch Ave Oreland PA 19075 Restoration and preservation 416000 Allied Universal Security Services PO Box 828854 Philadelphia PA 191828854 Security services 375000 Oliver Fire Protection & Security 501 Feheley Drive King of Prussia PA 19406 Safety services 374000 10 0 0 154000 0 37931000 10149000 178000 48234000 Research Contract Revenue 541700 4197000 4197000 0 0 0 0 0 0 4197000 4515000 0 0 4515000 0 0 0 0 5383000 0 0 5383000 40000 0 34000 0 6000 0 6000 0 0 6000 44426000 0 43104000 0 1322000 0 1322000 0 0 1322000 569000 154000 239000 330000 0 330000 Sales of Specialized Services 541700 190000 0 190000 0 282000 0 0 282000 472000 64459000 4197000 190000 11838000 2637000 1101000 1278000 258000 0 0 0 0 21939000 16391000 4998000 550000 1948000 1544000 375000 29000 4126000 2786000 1174000 166000 1506000 1125000 343000 38000 0 0 0 0 460000 0 460000 0 138000 0 138000 0 81000 0 81000 0 0 484000 0 484000 0 1938000 1007000 880000 51000 43000 0 42000 1000 1006000 726000 248000 32000 827000 150000 670000 7000 4137000 3658000 451000 28000 444000 316000 108000 20000 0 1326000 1163000 154000 9000 6826000 5986000 794000 46000 259000 0 259000 0 Subawards 9219000 9201000 18000 0 Lab supplies and equipment agreements 8349000 7815000 534000 0 Stipends 386000 386000 0 0 Tuition, honorarium, and events 266000 105000 157000 4000 357000 255000 102000 0 68702000 53715000 13748000 1239000 2360000 1532000 25316000 22990000 6301000 5555000 13151000 8772000 0 0 0 0 0 0 219000 259000 911000 940000 182241000 81845000 104511000 100396000 111615000 132935000 22171000 27444000 0 0 0 0 17250000 19661000 303805000 320484000 12433000 9403000 0 0 2400000 2929000 52601000 52601000 0 0 0 0 4006000 5387000 71440000 70320000 X 183952000 197494000 48413000 52670000 232365000 250164000 303805000 320484000 X -4243000 21700000 0 0 0 342000 X 0 1 X 1 1 1 X 45984000 45213000 59722000 51780000 48234000 250933000 45984000 45213000 59722000 51780000 48234000 250933000 250933000 44489000 19500000 20308000 22625000 9938000 116860000 97000 423000 104000 293000 851000 1768000 369561000 11379000 0.67900 0.65444 X Schedule A, Part II, Line 8 Include $5,383,000 royalties, $4,515,000 dividends and interest and $40,000 rent revenue Schedule A, Part II, Line 10 $569,000 non-charitable fundraising gross receipt and $82,000 miscellaneous income (power consumption refund, energy savings rebates, and credit card rebates), and $200,000 insurance proceeds. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 1 1 0 0 0 0 1 81000 0 0 81000 0 Schedule C, Part II-B, Line 1 The Wistar Institute engaged the services of two lobbying firms whose responsibilities are to provide government relations services to The Wistar Institute at the federal, state and local levels. Duties include monitoring and tracking legislation which may be of interest to The Wistar Institute, arranging meetings with legislators and arranging visits of legislators to The Wistar Institute, and assisting in finding funding sources for programs. In addition, a number of Wistar staff participate in advocacy on a regular basis by participating in visits to legislative offices in Harrisburg, PA and by hosting visits of state and federal legislators to The Wistar Institute. We also occasionally ask our board, employees or friends/volunteers to write letters or call their representatives regarding legislation that may impact Wistar. 0 0 X X X 0 45876000 28000 9161000 0 815000 0 54250000 50072000 51000 -3526000 0 721000 0 45876000 43529000 73000 7249000 0 779000 0 50072000 17652000 244000 26513000 0 880000 0 43529000 18352000 129000 19000 0 848000 0 17652000 0.66 0.25 0.09 0 0 0 685000 685000 0 95612000 36846000 58766000 0 0 0 0 0 84347000 44537000 39810000 0 1597000 462000 1135000 100396000 Alternative Investments 27444000 F 27444000 Beneficial interest in charitable remainder trusts 1078000 Beneficial interest in perpetual trusts 18583000 19661000 Accrued pension expense 3858000 Interest rate swap 1529000 5387000 X 86100000 21700000 0 0 -142000 21558000 64542000 0 -83000 -83000 64459000 68301000 0 0 0 273000 273000 68028000 0 674000 674000 68702000 Schedule D, Part III, Line 1 Collections consist of Family Memorabilia and other artifacts which are not used in the Institute's operations. Schedule D, Part III, Line 4 The Institute's collections constitute a history of medical science in Philadelphia and the history of vaccine development. The museum collections are tied to our deeds of trust and have significant historical value, as Wistar was established as the first independent nonprofit biomedical research Institute in the country. Schedule D, Part V, Line 4 Management determines the prudent use of the endowment funds to support general purposes and research and training programs as specified by the various endowment programs. Schedule D, Part X, Line 2 The Institute is a not-for-profit institute which has been determined by the Internal Revenue Service to be exempt from federal income taxes under Section 501(c) (3) of the Internal Revenue Code (IRC). The Institute accounts for uncertainties in income taxes in accordance with authoritative guidance, which prescribes a recognition threshold of more-likely-than-not to be sustained upon examination by the appropriate taxing authority. Measurement of the tax uncertainty occurs if the recognition threshold has been met. Management believes that there were no tax uncertainties that met the recognition threshold for the year 2019. Schedule D, Part XI, Line 2d Gain on split - interest agreements = $3,309,000. Change in cash surrender value of life insurance policies = $12,000. Pension - net loss = -$558,000. Interest rate swap net loss = -$2,421,000. Investment management fees = -$484,000. Schedule D, Part XI, Line 4b Other components are: Fundraising event expense = -$239,000. Rental expense = -$34,000. Unrelated business receipts = 190,000. Schedule D, Part XII, Line 2d Other components are: Fundraising event expenses = $239,000 and rental expenses = $34,000. Schedule D, Part XII, Line 4b Investment management and custodial fees = $484,000 and unrelated business revenues = $190,000. Central America and the Caribbean 0 0 Investments 16373000 0 0 16373000 1 0 1 1 1 0 Schedule F, Part IV, Line 3 Although Wistar maintains interests in these foreign corporations and partnerships, its ownership percentage did not meet the threshold for reporting on IRS Form 5471 and 8865. Wistar Gala 667000 105000 562000 0 0 5000 112000 11000 64000 Women & Science 56000 49000 7000 0 0 0 19000 4000 24000 0 723000 154000 569000 0 0 5000 131000 15000 88000 239000 330000 X X X 0 1 X X X X 0 0 0 0 0 0 0 1 0 Dario Altieri MD President & CEO, Director of Wistar Cancer Center 591239 0 0 0 36815 0 36400 0 3708 0 668162 0 0 0 David B Weiner Executive Vice President 352472 0 35500 0 8195 0 35513 0 671 0 432351 0 0 0 Jennifer Evans Stacey Vice President, Gen Counsel, Sec & Gov Relations 320290 0 10500 0 671 0 32800 0 11800 0 376061 0 0 0 Heather A Steinman VP for Business Develop & E. D. Tech 273036 0 53598 0 209 0 32121 0 7490 0 366454 0 0 0 Joseph Trainor Chief Financial Officer 243188 0 10500 0 1513 0 29961 0 17907 0 303069 0 0 0 Anita Pepper Vice President, Institutional Advancement 218452 0 10500 0 283 0 25464 0 3726 0 258425 0 0 0 JoAnn Mendel Vice President, Human Resources 190371 0 10500 0 691 0 23035 0 8210 0 232807 0 0 0 Luis Montaner Professor Vice President, Scientific Operations 357814 0 60500 0 29588 0 36400 0 23320 0 507622 0 0 0 Dmitry Gabrilovich Professor 311308 0 28156 0 2863 0 35847 0 12365 0 390539 0 0 0 Rugang Zhang Professor 246030 0 40500 0 1316 0 32566 0 17446 0 337858 0 0 0 Frank Rauscher Professor 245017 0 500 0 20733 0 31270 0 22720 0 320240 0 0 0 Meenhard Herlyn Professor 255479 0 500 0 2223 0 34378 0 20257 0 312837 0 0 0 Schedule J, Part I, Line 1a Tax Indemnification and gross-up payments include tuition benefits. Discretionary spending account includes social club dues for CEO only. All amounts included in taxable compensation. Schedule J, Part I, Line 1b Tax Indemnification and gross-up payments are provided with a written policy. Social club dues are provided via employment contract with CEO. Schedule J, Part I, Line 7 Non-fixed payments, in the form of bonuses (revenue is not a basis for a bonus), are approved by the board compensation committee. The bonuses are based on performance (including leadership). A Philadelphia Authority for Industrial Development 232237287 2017-12-28 52857000 Capital project financing 0 0 0 B Philadelphia Authority for Industrial Development 232237287 2017-12-28 4500000 Capital project financing line of credit 0 0 0 A 0 0 52857000 0 0 0 257000 0 0 0 52600000 0 2014 1 0 1 1 B 0 0 4500000 0 0 0 0 0 0 20000 0 4480000 0 0 0 1 A 0 0 1 1 0 0 0 0 0 0 1 B 0 0 1 1 0 0 0 0 0 0 1 A 0 0 1 0 1 1 PNC Bank 10 1 0 0 0 1 B 0 0 1 0 1 0 0 0 1 A 1 B 1 X 8 178000 NYSE 0 0 1 0 Schedule M, Part I, Line 9 The Number reported in column (b) line 9 is the number of contributions. Form 990, Header, Line A Filed timely Form 8868, Application for Extension of Time to File an Exempt Organization Return Form 990, Part VI, Section A, Line 2 Daniel Wheeler (Trustee) and Robert Fox (Trustee) have a family relationship. Robert Fox (Trustee) and Richard Horowitz (Trustee) have a business relationship. Morton Collins (Trustee) and David Weiner (Key Employee) have a business relationship. Form 990, Part VI, Section A, Line 7a The Academy of Natural Sciences at Drexel University and the Wistar Family have the right to designate representation to the Board of Trustees. The University of Pennsylvania approves appointments to the Board of Trustees under the Institute's founding deeds of trust. Form 990, Part VI, Section B, Line 11b The Form 990 is reviewed by the controller, external tax accountant, and CFO. After all adjustments are made, the draft is reviewed with senior management. The final draft of the Form 990 is then reviewed with the Audit Committee. The Institute then posts a copy to the Board's website and notifies members of its availability for their information prior to submission. Form 990, Part VI, Section B, Line 12c Covered persons are requested to submit Annual Disclosure of Potential Conflicts of Interest forms which are reviewed by management. Covered persons include the Wistar Institute's trustees, officers, "key employees," and the next 5 highly compensated employees. If an individual has any power or influence to approve or disapprove a contract or transaction proposed to be entered into between the institute and any entity or person having a significant relationship to that individual, that individual has a potential conflict of interest and may not participate in the process leading to the approval or disapproval of the contract or transaction unless underlying facts giving rise to the potential conflict of interest are disclosed and approval for participation is obtained. In the case of the Board of Trustees, no individual with a potential conflict of interest with respect to a contract or transaction or any other conflict of interest may vote to approve or disapprove the contract or transaction. Form 990, Part VI, Section B, Line 15 The Board of Trustees has delegated authority to oversee the compensation paid to the organization's executives to the Executive Evaluation and Compensation Committee made up exclusively of independent members of the board of Trustees. The Committee follows the procedures set forth in the IRS regulations under Section 4958 in making compensation decisions. In particular, the Committee annually conducts a review of executive compensation based on independent compensation survey information. At least every other year, the Committee engages an independent consultant to collect comparative compensation data and provide a written opinion on the reasonableness of the proposed compensation for executives. In 2019, the Committee based its review and approval of proposed compensation on independent data and a reasonableness opinion provided by an independent compensation expert during the year, as well as employee performance assessments and market trend information. The Committee documented its compensation decision in contemporaneous written minutes. Form 990, Part VI, Section C, Line 19 The Institute's governing documents and conflict of interest policy are available on the institute's website (www.wistar.org). The Institute's financial statements are available upon request. Form 990, Part XI, Line 9 Gain on split-interest agreements: $3,309,000. Change in cash surrender value of life insurance policies: $12,000. Pension - net loss: -$558,000. Interest rate swap - net loss: - $2,421,000. Issac J Wistar Foundation 3601 Spruce Street Philadelphia PA 19104 232593436 Inactive PA 501 (c) (3) PF N/A 0 Tall Cell Technology L P c/o The Connelly Fdn One Tower Bridge Suite 1450 West Conshohocken PA 19428 232811246 Licensing PA The Wistar Institute of Anatomy and Biology Related 323000 35000 0 1 0.9 Beneficial interest in charitable remainder trust PNC Wealth Management 620 Liberty Avenue Pittsburgh PA 15222 Trust PA PNC Bank T -15000 181000 1 0 Beneficial interest in perpetual trusts BNY Mellon Wealth Management 1735 Market Street Philadelphia PA 19103 Trusts PA BNY Mellon Bank T 2185000 16625000 1 0 Beneficial interest in perpetual trusts PNC Institutional Investments 620 Liberty Avenue Pittsburgh PA 15222 Trusts PA PNC Bank T 238000 1958000 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Tall Cell Technology L P a-iii 323000 We filed 8868 forms for form 990, form 990-PF and form 990-T.